Cargando…

Exploration on the Interaction Ability of Antitumor Compound Bis-[2,6-difluoro-N-(hydroxyl-<κ>O)benzamidato-<κ>O]dibutylitin(IV) with Human Peroxisome Proliferator-Activated Receptor hPPARγ

Diorganotin(IV) antitumor compound bis-[2,6-difluoro-N-(hydroxyl-<κ>O)benzamidato-<κ>O] (DBDF2,6T) was one of the novel patent organotin compounds with high antitumor activity and relatively low toxicity. In this study, several methods were used to study the interaction between DBDF2,6T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mai, Jiaqi, Li, Yunlan, Qiao, Xiaozhi, Ji, Xiaoqing, Li, Qingshan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015708/ https://www.ncbi.nlm.nih.gov/pubmed/29983705 http://dx.doi.org/10.1155/2018/3063271

Ejemplares similares

Aqua(benzamidato-κN)bis[3,5-difluoro-2-(pyridin-2-yl)phenyl-κC (1)]iridium(III) methanol monosolvate
por: Zhang, Songlin, et al.
Publicado: (2012)

Conditional Expression of Human PPARδ and a Dominant Negative Variant of hPPARδ In Vivo
por: Higgins, Larry G., et al.
Publicado: (2012)

catena-Poly[[trimethyltin(IV)]-μ-3,5-difluorobenzoato-κ(2) O:O′]
por: Liu, Hong, et al.
Publicado: (2011)

catena-Poly[[trimethyltin(IV)]-μ-2,5-difluorobenzoato-κ(2) O:O′]
por: Wen, Liyuan, et al.
Publicado: (2008)

Chlorido(chlorodifluoroacetato-κO)bis(1,10-phenanthroline-κ(2) N,N′)manganese(II)
por: Lo, Kong Mun, et al.
Publicado: (2008)

Bis(μ-4,4′′-difluoro-1,1′:3′,1′′-terphenyl-2′-carboxylato-κ(2) O:O′)bis[aqua(4,4′′-difluoro-1,1′:3′,1′′-terphenyl-2′-carboxylato-κO)(pyridine-κN)cobalt(II)] diethyl ether disolvate
por: Kim, Namseok, et al.
Publicado: (2012)

Dicyclohexylammonium bis(chlorodifluoroacetato-κO)cyclohexyldiphenylstannate(IV)
por: Teo, Yin Yin, et al.
Publicado: (2008)

Dicyclohexylammonium bis(chlorodifluoroacetato-κO)cyclopentyldiphenylstannate(IV)
por: Teo, Yin Yin, et al.
Publicado: (2008)

[2,6-Difluoro-3-(pyridin-2-yl-κN)pyridin-4-yl-κC (4)](pentane-2,4-dionato-κ(2) O,O′)iridium(III)
por: Luo, Kaijun, et al.
Publicado: (2013)

Bis(4,4′′-difluoro-1,1′:3′,1′′-terphenyl-2′-carboxylato-κO)tetrakis(methanol-κO)calcium methanol tetrasolvate
por: Kim, Namseok, et al.
Publicado: (2013)

Crystal structure of [2,6-difluoro-3-(pyridin-2-yl-κN)pyridin-4-yl-κC (4)](pentane-2,4-dionato-κ(2) O,O′)platinum(II)
por: Park, Ki-Min, et al.
Publicado: (2015)

Effect of Dibutyltin Dilaurate on Triglyceride Metabolism through the Inhibition of the mTOR Pathway in Human HL7702 Liver Cells
por: Qiao, Xiaozhi, et al.
Publicado: (2018)

Bis[μ-bis(diphenylphosphino)methane-κ(2) P:P′]bis[(chlorodifluoroacetato-κO)silver(I)](Ag—Ag)
por: Lo, Kong Mun, et al.
Publicado: (2008)

Di-μ-benzoato-κ(3) O,O′:O′;κ(3) O:O,O′-bis[aquabis(benzoato-κ(2) O,O′)(dimethylformamide-κO)europium(III)]
por: Wang, Zhiliang, et al.
Publicado: (2011)

Tetra-μ-benzoato-κ(4) O:O′;κ(3) O:O,O′;κ(3) O,O′:O′-bis[(benzoato-κ(2) O,O′)(1,10-phenanthroline-κ(2) N,N′)neodymium(III)]
por: Ooi, Ping Howe, et al.
Publicado: (2010)

Tetra-μ-acetato-κ(4) O:O′;κ(3) O,O′:O′;κ(3) O:O,O′-bis[(acetato-κ(2) O,O′)(1,10-phenanthroline-κ(2) N,N′)europium(III)]
por: Liu, Wen-Jing, et al.
Publicado: (2010)

Tetra-μ-acetato-κ(4) O:O′;κ(3) O,O′:O;κ(3) O:O,O′-bis[(acetato-κ(2) O,O′)(1,10-phenanthroline-κ(2) N,N′)europium(III)]
por: Fan, Rui-Qing, et al.
Publicado: (2010)

Bis[1,3-bis(diphenylphosphino)propane-κ(2) P:P′]silver(I) bis(chlorodifluoroacetato-κO)triphenylstannate(IV)
por: Teo, Yin Yin, et al.
Publicado: (2008)

catena-Poly[[[diacrylato-κ(4) O,O′-neodymium(III)]-di-μ-acrylato-κ(3) O,O′:O′;κ(3) O:O,O′-[triaquaneodymium(III)]-di-μ-acrylato-κ(3) O,O′:O′;κ(3) O:O,O′] trihydrate]
por: Hao, Lujiang, et al.
Publicado: (2008)

Di-μ-benzoato-κ(3) O,O′:O′;κ(3) O:O,O′-bis[(benzoato-κ(2) O,O′)(1,10-phenanthroline-κ(2) N,N′)cadmium]
por: Li, Hong-Jin, et al.
Publicado: (2011)

Tetra-μ-benzoato-κ(4) O:O′;κ(3) O:O,O′;κ(3) O,O′:O′-bis[(benzoato-κ(2) O,O′)(1,10-phenanthroline-κ(2) N,N′)terbium(III)] benzoic acid disolvate
por: Ooi, Ping Howe, et al.
Publicado: (2010)

Tetra-μ-benzoato-κ(4) O:O′;κ(3) O:O,O′;κ(3) O,O′:O′-bis[(benzoato-κ(2) O,O′)(1,10-phenanthroline-κ(2) N,N′)europium(III)] benzoic acid disolvate
por: Ooi, Ping Howe, et al.
Publicado: (2010)

Di-μ-benzoato-κ(3) O,O′:O;κ(3) O:O,O′-bis[(benzoato-κ(2) O,O′)(1,10-phenanthroline-κ(2) N,N′)lead(II)]
por: Li, Hong-Jin, et al.
Publicado: (2011)

Di-μ-nitrito-κ(3) O:O,O′;κ(3) O,O′:O-bis{[2,6-bis(pyrazol-1-yl-κN (2))pyridine-κN](nitrito-κ(2) O,O′)cadmium(II)}
por: Sun, Ting Ting, et al.
Publicado: (2009)

Di-μ-benzoato-κ(3) O,O′:O;κ(3) O:O,O′-bis[aqua(nitrato-κO)(1,10-phenanthroline-κ(2) N,N′)lead(II)]
por: Cheng, Yuanzheng, et al.
Publicado: (2012)

Di-μ-benzoato-κ(3) O,O′:O;κ(3) O:O,O′-bis[(acetato-κO)(1,10-phenanthroline-κ(2) N,N′)lead(II)] dihydrate
por: Gao, Junli, et al.
Publicado: (2009)

Bis(μ-quinoline-2-carboxylato)-κ(3) N,O:O;κ(3) O:N,O-bis[(acetato-κ(2) O,O′)(methanol-κO)lead(II)]
por: Mohammadnezhad, Gholamhossein, et al.
Publicado: (2010)

Forced expression of fibroblast growth factor 21 reverses the sustained impairment of liver regeneration in hPPARα(PAC) mice due to dysregulated bile acid synthesis
por: Liu, Hui-Xin, et al.
Publicado: (2015)

catena-Poly[[aqua(benzoato-κ(2) O,O′)(benzoic acid-κO)calcium]-μ(3)-benzoato-κ(4) O:O,O′:O′]
por: Azizov, Olimjon, et al.
Publicado: (2011)

Tetrakis(6-methyl-2,2′-bipyridine)-1κ(2) N,N′;2κ(2) N,N′;3κ(2) N,N′;4κ(2) N,N′-tetra-μ-nitrato-1:2κ(2) O:O′;2:3κ(3) O:O′,O′′;2:3κ(3) O,O′:O′′;3:4κ(2) O:O′-tetranitrato-1κ(4) O,O′;4κ(2) O,O′-tetralead(II)
por: Ahmadi, Roya, et al.
Publicado: (2009)

Di-μ-acetato-κ(3) O,O′:O;κ(3) O:O,O′-bis[(acetato-κ(2) O,O′)(1,10-phenanthroline-κ(2) N,N′)cadmium(II)]
por: Harvey, Miguel Angel, et al.
Publicado: (2008)

Bis(μ-4-methylbenzoato)-κ(3) O,O′:O;κ(3) O:O,O′-bis[aqua(4-methylbenzoato-κ(2) O,O′)(nicotinamide-κN (1))cadmium]
por: Dincel, Öznur, et al.
Publicado: (2012)

Bis(μ-2-methylquinolin-8-olato)-κ(3) N,O:O;κ(3) O:N,O-bis[(acetato-κO)(methanol-κO)zinc(II)]
por: Sattarzadeh, Elham, et al.
Publicado: (2009)

Tetrakis(μ-5-bromonicotinato)-κ(3) O,O′:O′;κ(3) O:O,O′;κ(4) O:O′-bis[diaqua(5-bromonicotinato-κ(2) O,O′)neodymium(III)] dihydrate
por: Huang, Jing, et al.
Publicado: (2011)

Tetrakis(μ(2)-3,4-dimethoxyphenylacetato)-κ(3) O,O′:O′;κ(3) O:O:O′;κ(2) O:O′;κ(2) O:O′-bis[(3,4-dimethoxyphenylacetato-κ(2) O,O′)(1,10-phenanthroline-κ(2) N,N)thulium(III)]
por: Liu, Jia-Lu, et al.
Publicado: (2009)

Bis(μ-2-methylquinolin-8-olato)-κ(3) N,O:O;κ(3) O:N,O-bis[(methanol-κO)(nitrato-κ(2) O,O′)lead(II)]
por: Mohammadnezhad Sh., Gholamhossein, et al.
Publicado: (2009)

Bis(μ-diisopropylhydoxylaminato)-κ(2) O:N;κ(2) O:O-bis[(diisopropylhydoxylaminato-κO)beryllium]
por: Berger, Raphael Johann Friedrich, et al.
Publicado: (2012)

Di-μ-acetato-κ(3) O,O′:O′;κ(3) O:O,O′-bis[(acetato-κ(2) O,O′)bis(5-nitro-1,10-phenanthroline-κ(2) N,N′)cadmium]
por: Cui, Fenghua, et al.
Publicado: (2011)

Tetrakis(μ-4-tert-butylbenzoato)-κ(4) O:O′;κ(3) O,O′:O′;κ(3) O:O,O′-bis[aqua(4-tert-butylbenzoato-κ(2) O,O′)(4-tert-butylbenzoic acid-κO)neodymium(III)]
por: Yang, Juan, et al.
Publicado: (2011)

Tetrakis(μ-4-tert-butylbenzoato)-κ(3) O:O,O′;κ(3) O,O′:O′;κ(4) O:O′-bis[aquabis(4-tert-butylbenzoato-κ(2) O,O′)(4-tert-butylbenzoic acid-κO)praseodymium(III)]
por: Dai, Jun, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_gef7t0ai379n2bub3bcj03ttvd